FDA-Drug2026-08-26Class IPROCESSING DEFECT

American Regent Papaverine HCl Injection recalled for glass and paraformaldehyde contamination

GLASSOTHERNationwide distributionDrugs

What this means

American Regent's Papaverine HCl Injection (60 mg/2 mL) has been found to contain particulate matter identified as glass and/or paraformaldehyde. The contamination affects one lot (25202, expiring 11/30/2026) distributed nationwide. This is a prescription injectable medication used to treat certain circulatory conditions.

  • If you have received or administered this medication from lot 25202, do not use it.
  • Contact your pharmacy or healthcare provider immediately if you have questions about whether you received an affected batch.
  • Report any adverse events or concerns to the FDA MedWatch program or your healthcare provider.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
86,100 vials
Manufactured in
5 Ramsay Rd, Shirley, NY, United States
Products
Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0800-2026

More American Regent recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.